Adamis stock soars as high as 480 percent amid asset sale, drug study news
| ADMPDelisted Stock | USD 1.74 0.24 12.12% |
Slightly above 62% of Adamis Pharma's investor base is looking to short. The analysis of current outlook of investing in Adamis Pharma suggests that many traders are alarmed regarding Adamis Pharma's prospects. Adamis Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Adamis Pharma. Many technical investors use Adamis Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Adamis |
Adamis stock rocketed Tuesday following news that it had sold certain assets and was funding additional research for its opioid overdose drug ZIMHI. Read more here.
Read at seekingalpha.com
 |
Adamis Pharma Fundamental Analysis
We analyze Adamis Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adamis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adamis Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Adamis Pharma is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Adamis Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adamis Pharma stock to make a market-neutral strategy. Peer analysis of Adamis Pharma could also be used in its relative valuation, which is a method of valuing Adamis Pharma by comparing valuation metrics with similar companies.
Peers
Adamis Pharma Related Equities
| EVOK | Evoke Pharma | 5.35 | ||||
| AQST | Aquestive Therapeutics | 0.96 | ||||
| ORGO | Organogenesis Holdings | 0.57 | ||||
| TLRY | Tilray | 3.42 | ||||
| LFCR | Lifecore Biomedical | 4.51 | ||||
| SHPH | Shuttle Pharmaceuticals | 6.12 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Adamis Stock
If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |